Galapagos said this week that Angus MacLeod has joined the company's service division BioFocus as director of medicinal chemistry.

MacLeod previously worked at Merck Sharp & Dohme, most recently as senior director of medicinal chemistry, Galapagos said.


Fisher Scientific said this week that President and CEO David Della Penta will retire at the end of 2006.

He has been with Fisher since 1998. The company said additional announcements regarding his successor will be made later in the year.

 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.